Releasing information in incremental steps is nothing new to software developers, who release updates and patches that add new functionality to existing programmes. The launch of a new bioinformatics tool is often accompanied by a paper describing the tool for new users. However, the paper describing the tool will be out of date as soon…
A year ago today, F1000Research launched its preliminary site. Among the very first papers published on that day was Manuel Corpas’ paper “Low budget analysis of Direct-To-Consumer genomic testing familial data”, in which he evaluated the potential of public domain analysis tools for personal genomics. Now, a year later, we followed up with Manuel to…
Ethan Perlstein left academia to become an independent researcher, investigating rare diseases. In this guest post, he explains how he arrived at this decision, and what his plans are. Recently I declared scientific independence and a newfound focus on rare/orphan diseases…on my blog. This decision was not planned far in advance. It’s more adaptation to…
Graham Steel has been involved in Patient Advocacy since 2001 and is a strong advocate and vocal supporter of Open Access, Open Data and Free Culture (interview). In the guest post below, Graham describes the importance of access to clinical trials, academic articles and data, as well as the personal events that led him to…
Since we launched F1000Research, many of you have been very active supporters of the journal. You’ve talked to colleagues, put up flyers, tweeted and blogged about us. Now, F1000 has launched an initiative that will give you some credit for supporting us: You can become an official F1000 Specialist. To find out more, you can…
This week, we’ve been posting about negative results on Twitter, and were joined by others who support the cause for the publication of negative results. Most notably, Nik Papageorgiou drew an amazing comic, which received a lot of attention, and even made it to WordPress.com’s “Freshly Pressed” highlights section! It was great to see so…
When we announced our campaign to waive the article processing fee for negative results articles until the end of August, we published a press release with a quote from Ben Goldacre, who has been fighting publication bias in medical research and clinical trials. He has talked about the issue in his book Bad Pharma and…
We recently came across The Paper Rejection Repository on the website of Niko Grigorieff’s group at Brandeis University. On this page, he showed from which journals some published papers had previously been rejected, and includes the rejection letters. We invited Niko to share some more details about this project in this guest post: My lab…
A couple of weeks ago, we interviewed F1000Research author Joel Huberman about his experiences with our journal. He published an article about the control of timing of telomere replication in fission yeast. In this study, he set out to investigate whether fission yeast telomere replication is similar to that of budding yeast, where replication timing…
Even though we just recently launched our campaign to encourage you to submit your negative results to F1000Research, we have a few papers with negative results in the journal already. One of these papers was Dianna Bartel’s work on taste nerve injury, which she performed in Thomas Finger’s lab at the University of Colorado Denver…
